ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer

Recruiting now

Conditions studied: Anal Cancer

In brief

Anal cancer is a rare disease, but the incidence is rising. About 200 patients will get this type of cancer yearly in Sweden. Curative treatment includes chemotherapy and radiotherapy. The prognosis is good, but some patients will have recurrent or persistent disease after concluded chemo-radiotherapy and will then be offered salvage surgery. Some patients develop distant metastases that can be treated with good results. The aim of this study is to identify and describe functional outcome in patients diagnosed with anal cancer. We will study patients from diagnosis, try to identify early toxicity to treatment and then identify long-term morbidity.

Key facts

Study ID

NCT04792892

Run by

Sahlgrenska University Hospital

People needed

600

Starts

2021-08-01

Expected to finish

2035-04-01

Last updated by the study team

2023-12-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 18 years
• Anal squamous carcinoma diagnosed within the last 2 months

You may not qualify if…

• No informed consent

Where it is running

• Dept. of Surgery, Sahlgrenska University Hospital/Ostra — Gothenburg, Sweden (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.